Study of Mycobacterium tuberculosis Thymidylate Synthases
Author Information
Author(s): Hunter Joshua H., Gujjar Ramesh, Pang Cullen K. T., Rathod Pradipsinh K.
Primary Institution: University of Washington
Hypothesis
The study aims to characterize the enzymatic properties of ThyA and ThyX from Mycobacterium tuberculosis to facilitate drug development.
Conclusion
The enzymatic characterization of ThyA and ThyX provides a foundation for developing inhibitors against Mycobacterium tuberculosis.
Supporting Evidence
- ThyA and ThyX are essential for the growth of Mycobacterium tuberculosis.
- FdUMP was identified as a potent inhibitor for both ThyA and ThyX.
- The study provides insights into the low turnover rates of the enzymes, raising questions about their biological roles.
Takeaway
Researchers studied two important enzymes in tuberculosis bacteria to help find new medicines to fight the disease.
Methodology
The study involved cloning, overexpressing, purifying the enzymes, and analyzing their kinetic properties and inhibitor binding.
Limitations
The study does not define the detailed metabolic role and vulnerability of Mycobacterium tuberculosis to inhibitors of these enzymes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website